nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—lung cancer—thymus cancer	0.809	1	CtDrD
Paclitaxel—Pruritus generalised—Octreotide—thymus cancer	0.00363	0.0298	CcSEcCtD
Paclitaxel—VIIth nerve paralysis—Octreotide—thymus cancer	0.00295	0.0242	CcSEcCtD
Paclitaxel—Pancreatitis acute—Octreotide—thymus cancer	0.00262	0.0215	CcSEcCtD
Paclitaxel—Sinus bradycardia—Octreotide—thymus cancer	0.00247	0.0203	CcSEcCtD
Paclitaxel—Loose stools—Octreotide—thymus cancer	0.00219	0.0179	CcSEcCtD
Paclitaxel—BCL2—neck—thymus cancer	0.00191	0.0275	CbGeAlD
Paclitaxel—Nail disorder—Octreotide—thymus cancer	0.00187	0.0153	CcSEcCtD
Paclitaxel—Redness—Octreotide—thymus cancer	0.00179	0.0147	CcSEcCtD
Paclitaxel—Intestinal obstruction—Octreotide—thymus cancer	0.00178	0.0146	CcSEcCtD
Paclitaxel—Neuralgia—Octreotide—thymus cancer	0.00174	0.0143	CcSEcCtD
Paclitaxel—Influenza-like symptoms—Octreotide—thymus cancer	0.00169	0.0139	CcSEcCtD
Paclitaxel—Throat sore—Octreotide—thymus cancer	0.00168	0.0138	CcSEcCtD
Paclitaxel—Oropharyngeal discomfort—Octreotide—thymus cancer	0.00166	0.0137	CcSEcCtD
Paclitaxel—MAP2—neck—thymus cancer	0.00166	0.0238	CbGeAlD
Paclitaxel—Neuritis—Octreotide—thymus cancer	0.00162	0.0133	CcSEcCtD
Paclitaxel—Herpes zoster—Octreotide—thymus cancer	0.00161	0.0132	CcSEcCtD
Paclitaxel—MAP4—hematopoietic system—thymus cancer	0.00157	0.0225	CbGeAlD
Paclitaxel—TUBB3—hematopoietic system—thymus cancer	0.00157	0.0225	CbGeAlD
Paclitaxel—TUBB1—hematopoietic system—thymus cancer	0.00153	0.022	CbGeAlD
Paclitaxel—Tingling sensation—Octreotide—thymus cancer	0.00151	0.0124	CcSEcCtD
Paclitaxel—MAPT—pituitary gland—thymus cancer	0.00148	0.0213	CbGeAlD
Paclitaxel—BCL2—hematopoietic system—thymus cancer	0.00142	0.0205	CbGeAlD
Paclitaxel—Sensory loss—Octreotide—thymus cancer	0.0014	0.0115	CcSEcCtD
Paclitaxel—Contusion—Octreotide—thymus cancer	0.00139	0.0114	CcSEcCtD
Paclitaxel—Extravasation—Octreotide—thymus cancer	0.00139	0.0114	CcSEcCtD
Paclitaxel—Breast pain—Octreotide—thymus cancer	0.00139	0.0114	CcSEcCtD
Paclitaxel—Rectal haemorrhage—Octreotide—thymus cancer	0.00134	0.011	CcSEcCtD
Paclitaxel—Viral infection—Octreotide—thymus cancer	0.00134	0.011	CcSEcCtD
Paclitaxel—Hyperbilirubinaemia—Octreotide—thymus cancer	0.00133	0.0109	CcSEcCtD
Paclitaxel—Cellulitis—Octreotide—thymus cancer	0.00133	0.0109	CcSEcCtD
Paclitaxel—Oropharyngeal pain—Octreotide—thymus cancer	0.00133	0.0109	CcSEcCtD
Paclitaxel—Herpes simplex—Octreotide—thymus cancer	0.00131	0.0108	CcSEcCtD
Paclitaxel—Drug interaction—Octreotide—thymus cancer	0.0013	0.0107	CcSEcCtD
Paclitaxel—BCL2—epithelium—thymus cancer	0.0013	0.0187	CbGeAlD
Paclitaxel—MAPT—thyroid gland—thymus cancer	0.00127	0.0183	CbGeAlD
Paclitaxel—Hearing impaired—Octreotide—thymus cancer	0.00127	0.0104	CcSEcCtD
Paclitaxel—MAP2—hematopoietic system—thymus cancer	0.00123	0.0177	CbGeAlD
Paclitaxel—Phosphatase alkaline increased—Octreotide—thymus cancer	0.00121	0.00994	CcSEcCtD
Paclitaxel—Injection site reaction—Octreotide—thymus cancer	0.0012	0.00988	CcSEcCtD
Paclitaxel—Influenza like illness—Octreotide—thymus cancer	0.00118	0.00965	CcSEcCtD
Paclitaxel—Wheezing—Octreotide—thymus cancer	0.00118	0.00965	CcSEcCtD
Paclitaxel—Candida infection—Octreotide—thymus cancer	0.00116	0.00949	CcSEcCtD
Paclitaxel—Neuropathy—Octreotide—thymus cancer	0.00114	0.00933	CcSEcCtD
Paclitaxel—Cramps of lower extremities—Octreotide—thymus cancer	0.00111	0.00913	CcSEcCtD
Paclitaxel—TUBB3—lymphoid tissue—thymus cancer	0.0011	0.0159	CbGeAlD
Paclitaxel—MAP4—lymphoid tissue—thymus cancer	0.0011	0.0159	CbGeAlD
Paclitaxel—Urine output increased—Octreotide—thymus cancer	0.00109	0.00898	CcSEcCtD
Paclitaxel—Mouth ulceration—Octreotide—thymus cancer	0.00109	0.00898	CcSEcCtD
Paclitaxel—Phlebitis—Octreotide—thymus cancer	0.00102	0.00837	CcSEcCtD
Paclitaxel—SLCO1B3—pituitary gland—thymus cancer	0.00102	0.0146	CbGeAlD
Paclitaxel—Thrombophlebitis—Octreotide—thymus cancer	0.00101	0.00833	CcSEcCtD
Paclitaxel—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.00101	0.00829	CcSEcCtD
Paclitaxel—BCL2—lymphoid tissue—thymus cancer	0.001	0.0144	CbGeAlD
Paclitaxel—MAP4—thyroid gland—thymus cancer	0.001	0.0144	CbGeAlD
Paclitaxel—Polyuria—Octreotide—thymus cancer	0.001	0.00821	CcSEcCtD
Paclitaxel—Deafness—Octreotide—thymus cancer	0.000982	0.00806	CcSEcCtD
Paclitaxel—TUBB1—bone marrow—thymus cancer	0.000982	0.0141	CbGeAlD
Paclitaxel—Cardiac failure congestive—Octreotide—thymus cancer	0.000969	0.00795	CcSEcCtD
Paclitaxel—Nasal congestion—Octreotide—thymus cancer	0.000964	0.00792	CcSEcCtD
Paclitaxel—Injury—Octreotide—thymus cancer	0.000956	0.00785	CcSEcCtD
Paclitaxel—TUBB4A—hematopoietic system—thymus cancer	0.000953	0.0137	CbGeAlD
Paclitaxel—Hot flush—Octreotide—thymus cancer	0.000939	0.00771	CcSEcCtD
Paclitaxel—MAP2—cardiac atrium—thymus cancer	0.000937	0.0135	CbGeAlD
Paclitaxel—Menopausal symptoms—Octreotide—thymus cancer	0.000931	0.00764	CcSEcCtD
Paclitaxel—Visual disturbance—Octreotide—thymus cancer	0.000927	0.00761	CcSEcCtD
Paclitaxel—MAP2—pituitary gland—thymus cancer	0.000915	0.0132	CbGeAlD
Paclitaxel—BCL2—bone marrow—thymus cancer	0.000913	0.0131	CbGeAlD
Paclitaxel—BCL2—thyroid gland—thymus cancer	0.00091	0.0131	CbGeAlD
Paclitaxel—TUBB3—lung—thymus cancer	0.00091	0.0131	CbGeAlD
Paclitaxel—MAP4—lung—thymus cancer	0.00091	0.0131	CbGeAlD
Paclitaxel—Hypoglycaemia—Octreotide—thymus cancer	0.0009	0.00739	CcSEcCtD
Paclitaxel—Pain in extremity—Octreotide—thymus cancer	0.000878	0.00721	CcSEcCtD
Paclitaxel—TUBB2A—hematopoietic system—thymus cancer	0.000867	0.0125	CbGeAlD
Paclitaxel—TUBB6—hematopoietic system—thymus cancer	0.000855	0.0123	CbGeAlD
Paclitaxel—BCL2—lung—thymus cancer	0.000827	0.0119	CbGeAlD
Paclitaxel—Dehydration—Octreotide—thymus cancer	0.000817	0.00671	CcSEcCtD
Paclitaxel—Dry skin—Octreotide—thymus cancer	0.000805	0.00661	CcSEcCtD
Paclitaxel—Abdominal pain upper—Octreotide—thymus cancer	0.000802	0.00659	CcSEcCtD
Paclitaxel—SLCO1B3—lung—thymus cancer	0.000796	0.0115	CbGeAlD
Paclitaxel—MAPT—lymph node—thymus cancer	0.000791	0.0114	CbGeAlD
Paclitaxel—Cramp muscle—Octreotide—thymus cancer	0.000791	0.00649	CcSEcCtD
Paclitaxel—MAP2—thyroid gland—thymus cancer	0.000789	0.0113	CbGeAlD
Paclitaxel—Nasopharyngitis—Octreotide—thymus cancer	0.000786	0.00645	CcSEcCtD
Paclitaxel—TUBB6—epithelium—thymus cancer	0.000782	0.0112	CbGeAlD
Paclitaxel—Muscular weakness—Octreotide—thymus cancer	0.000775	0.00636	CcSEcCtD
Paclitaxel—Abdominal distension—Octreotide—thymus cancer	0.000764	0.00627	CcSEcCtD
Paclitaxel—Influenza—Octreotide—thymus cancer	0.000759	0.00623	CcSEcCtD
Paclitaxel—ABCC10—hematopoietic system—thymus cancer	0.000749	0.0108	CbGeAlD
Paclitaxel—Pancreatitis—Octreotide—thymus cancer	0.000744	0.00611	CcSEcCtD
Paclitaxel—TUBB4B—hematopoietic system—thymus cancer	0.000743	0.0107	CbGeAlD
Paclitaxel—Sweating increased—Octreotide—thymus cancer	0.00074	0.00607	CcSEcCtD
Paclitaxel—Bronchitis—Octreotide—thymus cancer	0.00073	0.00599	CcSEcCtD
Paclitaxel—MAP2—lung—thymus cancer	0.000716	0.0103	CbGeAlD
Paclitaxel—Dysuria—Octreotide—thymus cancer	0.00071	0.00583	CcSEcCtD
Paclitaxel—Upper respiratory tract infection—Octreotide—thymus cancer	0.000706	0.00579	CcSEcCtD
Paclitaxel—Pollakiuria—Octreotide—thymus cancer	0.000701	0.00576	CcSEcCtD
Paclitaxel—TUBB2B—cardiac atrium—thymus cancer	0.0007	0.0101	CbGeAlD
Paclitaxel—Weight increased—Octreotide—thymus cancer	0.000691	0.00567	CcSEcCtD
Paclitaxel—Weight decreased—Octreotide—thymus cancer	0.000687	0.00564	CcSEcCtD
Paclitaxel—Hyperglycaemia—Octreotide—thymus cancer	0.000685	0.00562	CcSEcCtD
Paclitaxel—TUBB2B—pituitary gland—thymus cancer	0.000683	0.00983	CbGeAlD
Paclitaxel—Pneumonia—Octreotide—thymus cancer	0.000681	0.00559	CcSEcCtD
Paclitaxel—Depression—Octreotide—thymus cancer	0.000675	0.00554	CcSEcCtD
Paclitaxel—TUBB4A—lymphoid tissue—thymus cancer	0.000671	0.00965	CbGeAlD
Paclitaxel—Neuropathy peripheral—Octreotide—thymus cancer	0.000664	0.00545	CcSEcCtD
Paclitaxel—TUBB—cardiac atrium—thymus cancer	0.000662	0.00952	CbGeAlD
Paclitaxel—TUBB2A—cardiac atrium—thymus cancer	0.000658	0.00947	CbGeAlD
Paclitaxel—Urinary tract infection—Octreotide—thymus cancer	0.000658	0.0054	CcSEcCtD
Paclitaxel—Conjunctivitis—Octreotide—thymus cancer	0.000658	0.0054	CcSEcCtD
Paclitaxel—TUBB6—cardiac atrium—thymus cancer	0.000649	0.00934	CbGeAlD
Paclitaxel—TUBB—pituitary gland—thymus cancer	0.000647	0.0093	CbGeAlD
Paclitaxel—Haematuria—Octreotide—thymus cancer	0.000645	0.0053	CcSEcCtD
Paclitaxel—TUBB2A—pituitary gland—thymus cancer	0.000643	0.00925	CbGeAlD
Paclitaxel—Hepatobiliary disease—Octreotide—thymus cancer	0.00064	0.00526	CcSEcCtD
Paclitaxel—Epistaxis—Octreotide—thymus cancer	0.000639	0.00524	CcSEcCtD
Paclitaxel—Sinusitis—Octreotide—thymus cancer	0.000635	0.00521	CcSEcCtD
Paclitaxel—TUBB6—pituitary gland—thymus cancer	0.000634	0.00913	CbGeAlD
Paclitaxel—CYP19A1—hematopoietic system—thymus cancer	0.00063	0.00906	CbGeAlD
Paclitaxel—MAP4—lymph node—thymus cancer	0.000622	0.00895	CbGeAlD
Paclitaxel—Bradycardia—Octreotide—thymus cancer	0.000619	0.00508	CcSEcCtD
Paclitaxel—TUBB4A—thyroid gland—thymus cancer	0.000609	0.00877	CbGeAlD
Paclitaxel—Rhinitis—Octreotide—thymus cancer	0.000609	0.005	CcSEcCtD
Paclitaxel—Hypoaesthesia—Octreotide—thymus cancer	0.000605	0.00496	CcSEcCtD
Paclitaxel—Pharyngitis—Octreotide—thymus cancer	0.000603	0.00495	CcSEcCtD
Paclitaxel—TUBB6—lymphoid tissue—thymus cancer	0.000602	0.00866	CbGeAlD
Paclitaxel—Oedema peripheral—Octreotide—thymus cancer	0.000599	0.00491	CcSEcCtD
Paclitaxel—TUBB2B—thyroid gland—thymus cancer	0.000589	0.00847	CbGeAlD
Paclitaxel—CYP1B1—hematopoietic system—thymus cancer	0.000589	0.00847	CbGeAlD
Paclitaxel—Visual impairment—Octreotide—thymus cancer	0.000586	0.00481	CcSEcCtD
Paclitaxel—ABCC10—cardiac atrium—thymus cancer	0.000569	0.00818	CbGeAlD
Paclitaxel—Tinnitus—Octreotide—thymus cancer	0.000567	0.00465	CcSEcCtD
Paclitaxel—BCL2—lymph node—thymus cancer	0.000566	0.00814	CbGeAlD
Paclitaxel—TUBB4B—cardiac atrium—thymus cancer	0.000565	0.00812	CbGeAlD
Paclitaxel—Cardiac disorder—Octreotide—thymus cancer	0.000564	0.00463	CcSEcCtD
Paclitaxel—Flushing—Octreotide—thymus cancer	0.000564	0.00463	CcSEcCtD
Paclitaxel—TUBB—bone marrow—thymus cancer	0.000559	0.00804	CbGeAlD
Paclitaxel—TUBB—thyroid gland—thymus cancer	0.000557	0.00802	CbGeAlD
Paclitaxel—TUBB2A—bone marrow—thymus cancer	0.000556	0.008	CbGeAlD
Paclitaxel—ABCC10—pituitary gland—thymus cancer	0.000555	0.00799	CbGeAlD
Paclitaxel—TUBB2A—thyroid gland—thymus cancer	0.000554	0.00798	CbGeAlD
Paclitaxel—TUBB4A—lung—thymus cancer	0.000554	0.00796	CbGeAlD
Paclitaxel—TUBB4B—pituitary gland—thymus cancer	0.000551	0.00793	CbGeAlD
Paclitaxel—Immune system disorder—Octreotide—thymus cancer	0.000549	0.00451	CcSEcCtD
Paclitaxel—TUBB6—bone marrow—thymus cancer	0.000548	0.00789	CbGeAlD
Paclitaxel—TUBB6—thyroid gland—thymus cancer	0.000547	0.00787	CbGeAlD
Paclitaxel—Arrhythmia—Octreotide—thymus cancer	0.000543	0.00446	CcSEcCtD
Paclitaxel—Alopecia—Octreotide—thymus cancer	0.000537	0.00441	CcSEcCtD
Paclitaxel—TUBB2B—lung—thymus cancer	0.000535	0.0077	CbGeAlD
Paclitaxel—Mental disorder—Octreotide—thymus cancer	0.000532	0.00437	CcSEcCtD
Paclitaxel—Malnutrition—Octreotide—thymus cancer	0.000529	0.00434	CcSEcCtD
Paclitaxel—Erythema—Octreotide—thymus cancer	0.000529	0.00434	CcSEcCtD
Paclitaxel—ABCC10—lymphoid tissue—thymus cancer	0.000527	0.00758	CbGeAlD
Paclitaxel—TUBB4B—lymphoid tissue—thymus cancer	0.000523	0.00753	CbGeAlD
Paclitaxel—Flatulence—Octreotide—thymus cancer	0.000521	0.00428	CcSEcCtD
Paclitaxel—Tension—Octreotide—thymus cancer	0.000519	0.00426	CcSEcCtD
Paclitaxel—Nervousness—Octreotide—thymus cancer	0.000514	0.00422	CcSEcCtD
Paclitaxel—Back pain—Octreotide—thymus cancer	0.000512	0.0042	CcSEcCtD
Paclitaxel—Muscle spasms—Octreotide—thymus cancer	0.000509	0.00418	CcSEcCtD
Paclitaxel—TUBB—lung—thymus cancer	0.000506	0.00728	CbGeAlD
Paclitaxel—TUBB2A—lung—thymus cancer	0.000504	0.00724	CbGeAlD
Paclitaxel—Vision blurred—Octreotide—thymus cancer	0.000499	0.00409	CcSEcCtD
Paclitaxel—TUBB6—lung—thymus cancer	0.000497	0.00714	CbGeAlD
Paclitaxel—Tremor—Octreotide—thymus cancer	0.000496	0.00407	CcSEcCtD
Paclitaxel—Ill-defined disorder—Octreotide—thymus cancer	0.000491	0.00403	CcSEcCtD
Paclitaxel—MAP2—lymph node—thymus cancer	0.00049	0.00705	CbGeAlD
Paclitaxel—Anaemia—Octreotide—thymus cancer	0.000489	0.00401	CcSEcCtD
Paclitaxel—Agitation—Octreotide—thymus cancer	0.000486	0.00399	CcSEcCtD
Paclitaxel—ABCC10—bone marrow—thymus cancer	0.00048	0.0069	CbGeAlD
Paclitaxel—ABCC10—thyroid gland—thymus cancer	0.000479	0.00689	CbGeAlD
Paclitaxel—Malaise—Octreotide—thymus cancer	0.000477	0.00392	CcSEcCtD
Paclitaxel—TUBB4B—bone marrow—thymus cancer	0.000477	0.00686	CbGeAlD
Paclitaxel—TUBB4B—thyroid gland—thymus cancer	0.000475	0.00684	CbGeAlD
Paclitaxel—Vertigo—Octreotide—thymus cancer	0.000475	0.0039	CcSEcCtD
Paclitaxel—Syncope—Octreotide—thymus cancer	0.000474	0.00389	CcSEcCtD
Paclitaxel—Palpitations—Octreotide—thymus cancer	0.000467	0.00384	CcSEcCtD
Paclitaxel—Loss of consciousness—Octreotide—thymus cancer	0.000465	0.00382	CcSEcCtD
Paclitaxel—Cough—Octreotide—thymus cancer	0.000462	0.00379	CcSEcCtD
Paclitaxel—Convulsion—Octreotide—thymus cancer	0.000458	0.00376	CcSEcCtD
Paclitaxel—Hypertension—Octreotide—thymus cancer	0.000457	0.00375	CcSEcCtD
Paclitaxel—CYP2C8—hematopoietic system—thymus cancer	0.000451	0.00649	CbGeAlD
Paclitaxel—Chest pain—Octreotide—thymus cancer	0.00045	0.0037	CcSEcCtD
Paclitaxel—Myalgia—Octreotide—thymus cancer	0.00045	0.0037	CcSEcCtD
Paclitaxel—Arthralgia—Octreotide—thymus cancer	0.00045	0.0037	CcSEcCtD
Paclitaxel—Anxiety—Octreotide—thymus cancer	0.000449	0.00368	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.000447	0.00367	CcSEcCtD
Paclitaxel—Discomfort—Octreotide—thymus cancer	0.000445	0.00365	CcSEcCtD
Paclitaxel—Dry mouth—Octreotide—thymus cancer	0.00044	0.00362	CcSEcCtD
Paclitaxel—CYP1B1—pituitary gland—thymus cancer	0.000437	0.00628	CbGeAlD
Paclitaxel—ABCC10—lung—thymus cancer	0.000435	0.00626	CbGeAlD
Paclitaxel—TUBB4B—lung—thymus cancer	0.000432	0.00621	CbGeAlD
Paclitaxel—Oedema—Octreotide—thymus cancer	0.000432	0.00354	CcSEcCtD
Paclitaxel—Anaphylactic shock—Octreotide—thymus cancer	0.000432	0.00354	CcSEcCtD
Paclitaxel—Infection—Octreotide—thymus cancer	0.000429	0.00352	CcSEcCtD
Paclitaxel—Shock—Octreotide—thymus cancer	0.000425	0.00349	CcSEcCtD
Paclitaxel—Nervous system disorder—Octreotide—thymus cancer	0.000423	0.00348	CcSEcCtD
Paclitaxel—Thrombocytopenia—Octreotide—thymus cancer	0.000423	0.00347	CcSEcCtD
Paclitaxel—Tachycardia—Octreotide—thymus cancer	0.000421	0.00346	CcSEcCtD
Paclitaxel—Skin disorder—Octreotide—thymus cancer	0.000419	0.00344	CcSEcCtD
Paclitaxel—Hyperhidrosis—Octreotide—thymus cancer	0.000417	0.00343	CcSEcCtD
Paclitaxel—CYP1B1—lymphoid tissue—thymus cancer	0.000415	0.00596	CbGeAlD
Paclitaxel—Anorexia—Octreotide—thymus cancer	0.000412	0.00338	CcSEcCtD
Paclitaxel—CYP3A5—hematopoietic system—thymus cancer	0.000407	0.00585	CbGeAlD
Paclitaxel—CYP19A1—thyroid gland—thymus cancer	0.000403	0.00579	CbGeAlD
Paclitaxel—ABCC1—cardiac atrium—thymus cancer	0.000402	0.00578	CbGeAlD
Paclitaxel—CYP2C9—hematopoietic system—thymus cancer	0.000401	0.00576	CbGeAlD
Paclitaxel—Musculoskeletal discomfort—Octreotide—thymus cancer	0.000393	0.00323	CcSEcCtD
Paclitaxel—ABCC1—pituitary gland—thymus cancer	0.000393	0.00565	CbGeAlD
Paclitaxel—Insomnia—Octreotide—thymus cancer	0.00039	0.00321	CcSEcCtD
Paclitaxel—Paraesthesia—Octreotide—thymus cancer	0.000388	0.00318	CcSEcCtD
Paclitaxel—Dyspnoea—Octreotide—thymus cancer	0.000385	0.00316	CcSEcCtD
Paclitaxel—Somnolence—Octreotide—thymus cancer	0.000384	0.00315	CcSEcCtD
Paclitaxel—Dyspepsia—Octreotide—thymus cancer	0.00038	0.00312	CcSEcCtD
Paclitaxel—TUBB4A—lymph node—thymus cancer	0.000379	0.00545	CbGeAlD
Paclitaxel—CYP1B1—thyroid gland—thymus cancer	0.000377	0.00542	CbGeAlD
Paclitaxel—Decreased appetite—Octreotide—thymus cancer	0.000375	0.00308	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Octreotide—thymus cancer	0.000373	0.00306	CcSEcCtD
Paclitaxel—Fatigue—Octreotide—thymus cancer	0.000372	0.00306	CcSEcCtD
Paclitaxel—Constipation—Octreotide—thymus cancer	0.000369	0.00303	CcSEcCtD
Paclitaxel—Pain—Octreotide—thymus cancer	0.000369	0.00303	CcSEcCtD
Paclitaxel—TUBB2B—lymph node—thymus cancer	0.000366	0.00526	CbGeAlD
Paclitaxel—Feeling abnormal—Octreotide—thymus cancer	0.000356	0.00292	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Octreotide—thymus cancer	0.000353	0.0029	CcSEcCtD
Paclitaxel—TUBB—lymph node—thymus cancer	0.000346	0.00498	CbGeAlD
Paclitaxel—TUBB2A—lymph node—thymus cancer	0.000344	0.00495	CbGeAlD
Paclitaxel—Urticaria—Octreotide—thymus cancer	0.000343	0.00282	CcSEcCtD
Paclitaxel—CYP1B1—lung—thymus cancer	0.000342	0.00492	CbGeAlD
Paclitaxel—Abdominal pain—Octreotide—thymus cancer	0.000341	0.0028	CcSEcCtD
Paclitaxel—Body temperature increased—Octreotide—thymus cancer	0.000341	0.0028	CcSEcCtD
Paclitaxel—TUBB6—lymph node—thymus cancer	0.00034	0.00489	CbGeAlD
Paclitaxel—ABCC1—thyroid gland—thymus cancer	0.000339	0.00487	CbGeAlD
Paclitaxel—CYP2C8—pituitary gland—thymus cancer	0.000335	0.00481	CbGeAlD
Paclitaxel—ABCG2—pituitary gland—thymus cancer	0.000325	0.00468	CbGeAlD
Paclitaxel—Hypersensitivity—Octreotide—thymus cancer	0.000318	0.00261	CcSEcCtD
Paclitaxel—Asthenia—Octreotide—thymus cancer	0.00031	0.00254	CcSEcCtD
Paclitaxel—ABCC1—lung—thymus cancer	0.000308	0.00442	CbGeAlD
Paclitaxel—Pruritus—Octreotide—thymus cancer	0.000305	0.00251	CcSEcCtD
Paclitaxel—CYP3A4—hematopoietic system—thymus cancer	0.000305	0.00439	CbGeAlD
Paclitaxel—ABCC10—lymph node—thymus cancer	0.000297	0.00428	CbGeAlD
Paclitaxel—Diarrhoea—Octreotide—thymus cancer	0.000295	0.00243	CcSEcCtD
Paclitaxel—TUBB4B—lymph node—thymus cancer	0.000295	0.00425	CbGeAlD
Paclitaxel—Dizziness—Octreotide—thymus cancer	0.000286	0.00234	CcSEcCtD
Paclitaxel—ABCG2—bone marrow—thymus cancer	0.000281	0.00404	CbGeAlD
Paclitaxel—ABCG2—thyroid gland—thymus cancer	0.00028	0.00403	CbGeAlD
Paclitaxel—Vomiting—Octreotide—thymus cancer	0.000275	0.00225	CcSEcCtD
Paclitaxel—Rash—Octreotide—thymus cancer	0.000272	0.00223	CcSEcCtD
Paclitaxel—Dermatitis—Octreotide—thymus cancer	0.000272	0.00223	CcSEcCtD
Paclitaxel—Headache—Octreotide—thymus cancer	0.00027	0.00222	CcSEcCtD
Paclitaxel—Nausea—Octreotide—thymus cancer	0.000256	0.00211	CcSEcCtD
Paclitaxel—ABCG2—lung—thymus cancer	0.000255	0.00366	CbGeAlD
Paclitaxel—CYP19A1—lymph node—thymus cancer	0.00025	0.0036	CbGeAlD
Paclitaxel—ABCC2—lymph node—thymus cancer	0.000239	0.00344	CbGeAlD
Paclitaxel—CYP3A5—lung—thymus cancer	0.000236	0.0034	CbGeAlD
Paclitaxel—CYP1B1—lymph node—thymus cancer	0.000234	0.00336	CbGeAlD
Paclitaxel—ABCB1—hematopoietic system—thymus cancer	0.000216	0.00311	CbGeAlD
Paclitaxel—ABCC1—lymph node—thymus cancer	0.00021	0.00303	CbGeAlD
Paclitaxel—ABCB1—epithelium—thymus cancer	0.000198	0.00284	CbGeAlD
Paclitaxel—ABCG2—lymph node—thymus cancer	0.000174	0.00251	CbGeAlD
Paclitaxel—ABCB1—pituitary gland—thymus cancer	0.00016	0.00231	CbGeAlD
Paclitaxel—ABCB1—lymphoid tissue—thymus cancer	0.000152	0.00219	CbGeAlD
Paclitaxel—ABCB1—bone marrow—thymus cancer	0.000139	0.00199	CbGeAlD
Paclitaxel—ABCB1—thyroid gland—thymus cancer	0.000138	0.00199	CbGeAlD
Paclitaxel—ABCB1—lung—thymus cancer	0.000126	0.00181	CbGeAlD
Paclitaxel—ABCB1—lymph node—thymus cancer	8.59e-05	0.00124	CbGeAlD
